US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

95.67

+2.302.46%

Volume:10.42K

Turnover:991.30K

Market Cap:415.21M

PE:53.35

High:95.68

Open:93.80

Low:93.80

Close:93.37

52wk High:98.82

52wk Low:67.69

Shares:4.34M

Float Shares:4.34M

Volume Ratio:0.92

T/O Rate:0.24%

Dividend:1.55

Dividend Rate:1.62%

EPS(TTM):1.79

EPS(LYR):18.65

ROE:24.76%

ROA:0.08%

PB:1.68

PE(LYR):5.13

Loading ...

Overview Company News Filings

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley

Alnylam price target raised to $260 from $230 at Jefferies

Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

Why Amgen Stock is Dropping After Swiss Rival's Trial Setback

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Stocks to Watch: Amgen, Nike, Bloom Energy

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

Royalty Pharma Announces Update on Novartis’ Phase 3 Topline Results for Pelacarsen

THOMSON REUTERS

Royalty Pharma - Expects to Recoup Investment and Earn Modest Return Despite Pelacarsen Failure

THOMSON REUTERS

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Amgen is Maintained at Equal-Weight by Wells Fargo

This Biotech Wins a Big FDA Approval. Why Wall Street is Shrugging.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PBE/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":95.6698,"timestamp":1789675200000,"preClose":93.3693,"halted":0,"volume":10419,"delay":0,"changeRate":0.02463871957913361,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"Pre-Mkt","change":2.3005,"latestTime":"09-18 04:43:13 EDT","open":93.8,"high":95.68,"low":93.8,"amount":991296.323565,"amplitude":0.020135,"askPrice":109.37,"askSize":100,"bidPrice":82.22,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":95.6698,"sharesOutstanding":3180000,"nav":93.36109,"aum":407054352.4,"dividendRate":0.016201,"bidAskSpread":0.002094,"postHourTrading":{"tag":"盘后","latestPrice":95.68,"preClose":95.6698,"latestTime":"19:30 EDT","volume":12,"amount":1147.2384,"timestamp":1789687804713,"change":0.0102,"changeRate":0.000107,"amplitude":0},"volumeRatio":0.9184752799413084,"impliedVol":0.1148,"impliedVolPercentile":0.04},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":0.9184752799413084,"shares":4340000,"dividePrice":1.5499,"high":95.68,"amplitude":0.020135,"preClose":93.3693,"low":93.8,"week52Low":67.69,"pbRate":"1.68","psRate":"241.87","week52High":98.82,"institutionHeld":0.2552,"latestPrice":95.6698,"eps":1.793292,"divideRate":0.016201,"volume":10419,"delay":0,"ttmEps":1.793292,"open":93.8,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":93.03,"twentyDayClose":98.2643,"sixtyDayClose":85.4379},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"},{"executeDate":"2020-03-23","recordDate":"2020-03-24","paymentDate":"2020-03-31","value":0.02898,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665932217","title":"Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665932217?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:05","pubTimestamp":1788865500,"startTime":"0","endTime":"0","summary":"Stock futures were dropping on Tuesday as oil prices neared $100 a barrel, bolstering the case for the Federal Reserve to hike interest rates next week.Artificial-intelligence stocks were rising despite the market's inflation worries. Chip maker Intel was the S&P 500's top performer ahead of the opening bell, advancing 3.6%. Advanced Micro Devices, Marvell, Micron, and Sandisk were also up in premarket trading.Amgen fell 4.9% after drugmaker Novartis reported disappointing trial results for its experimental cardiovascular treatment, pelacarsen. Amgen is developing a treatment of its own called olpasiran. Novartis' Swiss-listed shares dropped 9.1% following a series of trial setbacks.Fuel-cell manufacturer Bloom Energy jumped 5.9%, data storage company Everpure added 3%, and biotech Illumina ticked up 0.9%. The stocks are set to join the S&P 500 before trading opens on Sept. 21.Building supplier Builders FirstSource, brewer Molson Coors Beverage, and advertising software company Trade D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU2860962120.EUR","LU0048584097.USD","LU2112291526.USD","LU0742534661.SGD","SGXZ99366536.SGD","GAMR","SINTCmain","GNMX","LU1989764748.USD","LU2506951792.HKD","LU2272731782.SGD","AMDW","LU2417539215.USD","IE00BMPRXQ63.HKD","LU0289739699.SGD","LU0251131958.USD","LU0868494617.USD","LU0786609619.USD","DTCR","LU2249611893.SGD","LU0823421416.USD","04332","LU2357627491.SGD","BK4602","LU1861220033.SGD","AMDS","LU1803068979.SGD","LU1988902786.USD","PJP","AMDD","LU1989772923.USD","TTEQ","LU2272731600.USD","LU2250418816.HKD","BK4121","CHAT","IE00BZ1G4Q59.USD","IE00BMPRXN33.USD","LU0957808578.USD","LU0823434583.USD","LU2089984988.USD","WISE","IBBQ","LU0187121727.USD","LU2247934214.USD","LU2361044865.SGD","LU0122379950.USD","BK4139","LU0058720904.USD","VTWG","AIFD","AMYY","LU0823414551.USD","BK4007","MRVU","CTEC","LU0348723411.USD","AMD","SOXY","AMDC","LU0390134368.USD","LU1169590202.USD","LU1992135399.USD","LU1023059063.AUD","WUGI","DAMD","LU0061475181.USD","MVLL","TTDU","PSI","LU1815336760.USD","BK4529","LU2764263203.CNY","SIMS","IE00B2B36J28.USD","IBAT","IBB","IETC","AIS","IE00BLSP4452.SGD","LU2242646821.SGD","WATS","BK4612","IE00BMPRXR70.SGD","NVSEF","GNOM","LU0823434740.USD","LU1242518857.USD","IE00BJJMRZ35.SGD","LU0274383776.USD","GTEK","LU2458330243.SGD","LU0719512351.SGD","ICLN","ARTY","LU2242649171.HKD","LU2265009873.SGD","BK4533","LU0979878070.USD","IE000WAW04H5.SGD","LU0444973449.USD","LU0133085943.USD","LU2322448957.HKD","LU2462591350.SGD","BK4588","LU0444971666.USD","IE0001KFT4U8.USD","BK4614","LU1261432733.SGD","LU2290526834.HKD","ILMN","IE00BJT1NW94.SGD","LU0128526141.USD","LU2456880835.USD","LU0210536198.USD","LU1861215975.USD","BK4527","LU1989772840.SGD","LU1880398554.USD","BK4550","BE","BIB","INTC","BK4534","LU0321505439.SGD","BK4141","LU2468319806.SGD","BK4605","LU0056508442.USD","IE00BN8TJ469.HKD","LU2360107168.USD","IE00BQXX3C00.GBP","SGXZ51526630.SGD","LU2764263039.SGD","LU1642822529.SGD","BK4573","INYY","LU2764262908.HKD","IE000BZT7R73.USD","LU1720051017.SGD","SOXX","IE00B4R5TH58.HKD","LU0174119429.USD","LU2896262040.SGD","LU0889565916.HKD","LU1571399168.USD","BK4515","LU2272731865.HKD","SMH","VCLN","LU2361045086.USD","LU2461242641.AUD","TRFK","BEG","LU2242652126.USD","LU1548497426.USD","LU2720916845.USD","INTW","IE0004086264.USD","LU2357305700.SGD","BK4581","LU0251132253.USD","LU1983299246.USD","IE0009354923.USD","BK4182","BK4532","IE00BQXX3D17.EUR","LU2098885051.SGD","LU2360106780.USD","LU1880398471.USD","EGGY","CHPS","LU0109392836.USD","LU2264538146.SGD","FDTX","LU2294711713.HKD","BEC","LU0149725797.USD","LU0320765992.SGD","BK4579","LU1720051108.HKD","FRNW","IE00B1BXHZ80.USD","AMDY","IE00BLSP4239.USD","LU2054465674.USD","LINT","DRIV","LU0198837287.USD","BK4604","LU1823568750.SGD","LU2458330169.SGD","LU1951198990.SGD","AMDU","LU1852331112.SGD","TTD","LU0823421333.USD","LU1119994496.HKD","LU1923623000.USD","LU0889566641.SGD","LU1232071149.USD","IE0000B7K699.USD","LU1316542783.SGD","BK4535","BBH","BK4613","LU1989764664.SGD","LEGR","CNRG","IE0009356076.USD","AMDL","IE00B5949003.HKD","SG9999001440.SGD","LU2355687059.USD","BK4585","SMOG","AMDG","LU2931357623.SGD","IE00BKVL7J92.USD","SG9999001424.SGD","LU1235294995.USD","IE0009355771.USD","SMHX","IE0004445239.USD","LU0082616367.USD","PBE","LU1046421795.USD","BK4023","LU0154236417.USD","LU1064131342.USD","LU1951200564.SGD","ILDR","LU2236285917.USD","IE000SO60NU8.SGD","FAI","XNTK","LU1169589451.USD","IE00BBT3K403.USD","LU1861558580.USD","SG9999000418.SGD","UPGR","LU1084165304.USD","MRVL","QQQA","TBXU","IE000F7OJYX1.SGD","LU0109394709.USD","LU1303367103.USD","LU0048573561.USD","BK4548","HK0000304797.USD","LU1992135472.HKD","BK4541","LU1861559042.SGD","LU2543165471.USD","SAMD0main","IE000MB6IJN5.SGD","USXF","LU1057294990.SGD","BK4575","AMUU","LU0792757196.USD","LU2473716301.USD","BK4528","LU0029874061.USD","LU0476273544.USD","IE00BQXX3F31.USD","LU0889565833.HKD","BK4009","LU2361044949.HKD","LU0859254822.USD","BK4599","BK4543","LU0081259029.USD","LU1242518931.SGD","IE0002141913.USD","04335","LU1804176565.USD","FTXL","MRVX","LU2357125470.USD","BEZ","BEX","SGXZ81514606.USD","LU1061106388.HKD","ZAP","BK4554","LU2244417387.USD","LU0127658192.USD","AMGN","LU1267930813.SGD","LU2108987350.USD","IE00BFTCPJ56.SGD","LU0321505868.SGD","FXL","HK0000304805.HKD","LU0823414478.USD","LU0642271901.SGD","BAI","TEK","AIQ","INT","LU0097036916.USD","LU2148611432.USD","BK4566","IE0004091025.USD","LU2089985449.USD","BK4512","LU2322448791.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665617322","title":"Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2665617322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665617322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:56","pubTimestamp":1788864960,"startTime":"0","endTime":"0","summary":"Morgan Stanley says conditions are ripe for software, healthcare and bank stocksMorgan Stanley says a new class of stocks is getting ready to emerge.Labor Day marks the final stretch of what's been a pretty good year for stocks. The S&P 500 SPX is up 14% this year, the small-cap Russell 2000 RUT has gained 20%, semiconductor stocks SOX have soared, basically everything but the Magnificent Seven is returning double digits.Stock-market strategists at Morgan Stanley led by Mike Wilson said that performance is no accident. \"This has all coincided with what we have deemed a new economic cycle that began at the trough of the rolling recession around Liberation Day in April 2025. The reacceleration in sales growth has led to a V-shaped rebound in EPS [earnings per share] growth as operating leverage returned to the median company,\" they say.But the one part of the market that has cooled are so-called momentum stocks, whose precise definitions vary but basically are bets that fast-rising stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710400.SGD","BK4566","IE00BFTCPJ56.SGD","LU0158827781.USD","BK4127","LU2468319806.SGD","BK4599","VTV","KBWB","QTOC","BK4532","EDOG","PJP","PPH","LU0225283273.USD","TBXU","IMCG","LU0164881194.USD","AMGN","BAMA","MEDX","INFY","IE00B775SV38.USD","LU1989772923.USD","PLGI","SG9999001440.SGD","NVS","IE00BYTNYM70.SGD","IBBQ","LU0267386448.USD","IBB","IE00B2B36J28.USD","CGDV","IAI","RULE","EQRR","LU0210528500.USD","BBH","BK4523","IE00B3S45H60.SGD","LU2242652126.USD","HIDV","IE00BJT1NW94.SGD","PBE","LU0868486357.SGD","LU1023059063.AUD","BK4535","LU0122379950.USD","BIB","FT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665308322","title":"Alnylam price target raised to $260 from $230 at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2665308322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665308322?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:45","pubTimestamp":1788864321,"startTime":"0","endTime":"0","summary":"Jefferies raised the firm’s price target on Alnylam (ALNY) to $260 from $230 and keeps a Hold rating on the shares. After a recent recovery, the fi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-price-target-raised-to-260-from-230-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-price-target-raised-to-260-from-230-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU0882574055.USD","BK4139","BK4548","BK4585","LU0889565916.HKD","LU0114720955.EUR","GNMX","BK4588","LU0320765992.SGD","ALNY","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665839324","title":"Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665839324","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665839324?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:22","pubTimestamp":1788862967,"startTime":"0","endTime":"0","summary":"BUZZ-Ionis Pharma tumbles after heart drug fails late-stage trial** Ionis Pharmaceuticals'IONS.Oshares fall 12.7% to $50.70 premarket** NovartisNOVN.Sand Ionis said late Friday their experimental drug pelacarsendid not cutthe risk of major heart attacks and strokes in patients with a genetic risk factor in a late-stage trial** The drug successfully lowered a dangerous genetic cholesterol, Lp, but it did not improve overall heart health outcomes** The trial failure was negative for biopharma sector perception because lowering Lp \"did not reduce cardiovascular events in the overall population\", say analysts at Leerink Partners**Amgen'sAMGN.Oand Eli Lilly'sLLY.Ndrugs \"lower Lp more than pelacarsen\" and could now facegreater scrutiny- brokerage** Amgen shares slip 5% to $415.01 before the bell** As of last close, IONS down 26.6% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500PU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE0002141913.USD","BK4581","LU1571399168.USD","IE0009355771.USD","BK4566","BK4585","TBXU","AMGN","IBBQ","LU1057294990.SGD","BK4139","LU2242652126.USD","LU0058720904.USD","LU0289739699.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4599","LU0889565916.HKD","PJP","BIB","LU2468319806.SGD","LU0868494617.USD","LU0122379950.USD","LU2089984988.USD","LU0109394709.USD","BK4588","IE00BJT1NW94.SGD","IBB","LU2112291526.USD","PBE","04332","BBH","IONS","IE00B2B36J28.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK4534","LU1023059063.AUD","SG9999001440.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665232106","title":"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232106?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0417517546.SGD","LU0823416689.USD","LU0211328371.USD","SMMT","LU0965509010.AUD","LU2125909247.SGD","AGNG","VHT","FHLC","LU0859254822.USD","LU1291159041.SGD","XBI","FTXH","LU0861579265.USD","LU0553294199.USD","LU1929549753.HKD","HCSG","IHE","LU0211327993.USD","IE00BVYPNV92.GBP","LU0128525929.USD","LU2347655073.USD","RXL","LU2237443549.SGD","MEDX","IYH","LU1037948897.HKD","LU0689626769.HKD","LU2433249047.HKD","LU1057294990.SGD","PBE","LU0029874061.USD","GLAM","JDOC","ABBV","TRUH","IE0004445239.USD","LU1244550494.USD","IE000BZT7R73.USD","BK4137","LABU","BK4550","LU1003077747.HKD","LU1551013342.USD","PPH","RPRX","IE00B3PB1722.GBP","IXJ","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665147329","title":"Why Amgen Stock is Dropping After Swiss Rival's Trial Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665147329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665147329?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:53","pubTimestamp":1788861180,"startTime":"0","endTime":"0","summary":"Big Pharma has been scrambling to restock its pipelines this year-so a disappointing trial from one drugmaker can have an outsize knock-on impact for rivals trying to develop similar treatments.That d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU0289739699.SGD","IBB","BBH","PBE","LU0122379950.USD","LU2242652126.USD","IBBQ","BIB","LU0109394709.USD","LU0058720904.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1057294990.SGD","BK4139","TBXU","LU0868494617.USD","IE00BFTCPJ56.SGD","PJP","IE0009355771.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1571399168.USD","LU1061106388.HKD","LU1983299246.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4566","LU2468319806.SGD","AMGN","LU0320765992.SGD","BK4585","BK4534","BK4533","LU2242646821.SGD","BK4581","IE0002141913.USD","SG9999001440.SGD","LU2112291526.USD","LU2089984988.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326246","title":"Amgen Falls After Novartis Trial Setback, BMO Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326246?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859626,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen falls after Novartis trial setback, BMO downgrade** Shares of AmgenAMGN.Oslip 4.8% to $416 premarket** Novartis'NOVN.Scholesterol drug failed in a closely watched study,raising concernsfor ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BIB","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","IBB","BBH","IE0009355771.USD","LU1061106388.HKD","LU2089984988.USD","LU1023059063.AUD","BK4588","LU2242652126.USD","BK4585","LU2242646821.SGD","LU0122379950.USD","LU1571399168.USD","LU1057294990.SGD","IBBQ","BK4581","BK4533","IE0002141913.USD","BK4599","LU0889565916.HKD","PBE","LU1983299246.USD","AMGN","IE00BJJMRZ35.SGD","LU0868494617.USD","LU0289739699.SGD","TBXU","LU2112291526.USD","BK4534","BK4566","LU0109394709.USD","LU0320765992.SGD","BK4139","LU2468319806.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342326","title":"Stocks to Watch: Amgen, Nike, Bloom Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858420,"startTime":"0","endTime":"0","summary":"Amgen : Shares of the biotechnology company, a major contributor to the Dow, shed more than 5% premarket after the Swiss drugmaker Novartis  said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial. Amgen and Eli Lilly  are working on rival treatments. Novartis shares tumbled 10% in Europe, while Eli Lilly shares ticked down.Bloom Energy : The fuel-cell maker is among the companies that will join the S&P 500 later this month, S&P Dow Jones Indices announced late Friday, sending its shares 4% higher premarket. Meanwhile, Nike  will be deleted from the S&P 100. Its shares edged lower premarket.Coinbase Global , Robinhood Markets , Strategy : Shares of companies tied to cryptocurrencies retreated in premarket trading as bitcoin's price slipped more than 1% to trade below $78,500.GameStop  is set to report earnings after markets close.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BE","LU0211331839.USD","ROBN","LU0109394709.USD","CTEC","MSTK","BK4146","LU1861558580.USD","BK4112","FINX","07799","MSTU","IE00B2B36J28.USD","WNTR","ICLN","3LMI.UK","MSTW","LU0128525689.USD","IE00BYQQ9H92.USD","HOOY","LU1064131342.USD","BK4600","CONY","LU1303367103.USD","BK4595","LU0310800965.SGD","LU0823414478.USD","BK4139","LU0289739699.SGD","BEZ","LU2089984988.USD","07711","BK4558","MSTC","IBB","COII","BK4539","LU0070302665.USD","LU2249611893.SGD","LU0823414551.USD","GMEY","HOOG","GMEC","LU2543165471.USD","NKE","STYL","BK4534","LU2468319806.SGD","MSTY.UK","MSTR","SMST","BK4007","COIN","LU1267930813.SGD","LU1267930227.SGD","MSST","IE0002141913.USD","MSDD","SG9999001440.SGD","LU2098885051.SGD","LU1057294990.SGD","MSTY","GME","HOOI","LU2294711713.HKD","LU0476273544.USD","BBH","NVS","BK4551","LU1642822529.SGD","HOYY","BIB","HOOC","BK4581","LU1267930573.SGD","PPH","BK4561","LMI3.UK","CNRG","GMEU","MSTZ","WATS","BK4516","LU1861217088.USD","PJP","CONX","09799","BEX","IE00BFXG0V08.USD","ICOI","LU2242646821.SGD","COYY","LU0889566641.SGD","BK4535","ZAP","3SMI.UK","SMI3.UK","SMOG","UPGR","IE0009354923.USD","FIAT","LU0029864427.USD","CONI","DAPP","LU0957808578.USD","LU2360107671.USD","BK4532","BK4554","MST","HOOD","TBXU","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4023","MEDX","LU0786609619.USD","COIA","BKCH","LU0052756011.USD","BK4585","09711","PBE","LU0320765489.SGD","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU2242652126.USD","LU0058720904.USD","LU1061106388.HKD","IE00BJT1NW94.SGD","LU1988902786.USD","IGME","MSTP","COIG","HOOX","BPAY","BK4599","LU0708994859.HKD","FRNW","COIO","IMST","07311","LU2506951792.HKD","LU1861559042.SGD","BK4076","SIMS","LU0889565916.HKD","LU0320765992.SGD","BEC","MSII","MTYY","FDIG","04332","LU0792757196.USD","HOOW","LU0868494617.USD","VCLN","LU1861220207.SGD","HOOZ","LU0122379950.USD","LU2112291526.USD","LU0444973449.USD","LU1571399168.USD","BEG","MSOO","LU1023059063.AUD","MSTX","CRPT","IBLC","LU0208291251.USD","LU1815336760.USD","BK4547","LU2357125470.USD","CONL","HOII","BK4533","AMGN","IBBQ","BK4588","OWNB","LU1983299246.USD","COIX","BK4566","LU2264538146.SGD","HODU","07399","09311","IAI","BITQ","IBAT","09399","BK4182","BK4596","COIW","BLCK","EGGY","LU0128525929.USD","LU0444971666.USD","BK4577","BK4127","APED","VTWG","BK4541","LU0823411888.USD","IE0009355771.USD","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665230393","title":"Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665230393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665230393?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:27","pubTimestamp":1788856044,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4581","BBH","LU0289739699.SGD","LU2242646821.SGD","LU2468319806.SGD","IE0009355771.USD","TBXU","LU0058720904.USD","LU1571399168.USD","IE00B4R5TH58.HKD","LU0122379950.USD","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4599","LU2112291526.USD","IE0002141913.USD","LU0889565916.HKD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0109394709.USD","LU1061106388.HKD","LU0868494617.USD","IE00BFTCPJ56.SGD","IBBQ","IBB","LU0320765992.SGD","BK4533","BK4534","LU1983299246.USD","AMGN","LU2242652126.USD","SG9999001440.SGD","BK4588","BIB","BK4585","PBE","PJP","LU1057294990.SGD","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532340","title":"Why the Dow is Being Dragged Down by a Swiss Company's Bad News","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:15","pubTimestamp":1788855300,"startTime":"0","endTime":"0","summary":"Bad news from Swiss pharmaceutical giant Novartis was weighing on the Dow on Tuesday.Investors returning from the Labor Day break could be forgiven for wondering if their eyes were deceiving them, but","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BK4533","NVS","BK4532","NAMS","BK4581","IE00B2B36J28.USD","LU1983299246.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0002141913.USD","LU2112291526.USD","LU0070302665.USD","AMGN","LU1057294990.SGD","IBBQ","LU2242652126.USD","LU0109394709.USD","LU0889565916.HKD","LU1571399168.USD","LU0320765489.SGD","BK4139","LU0211331839.USD","SG9999001440.SGD","IBB","TBXU","LU0058720904.USD","LU0320765992.SGD","BK4566","PPH","BBH","IE00BJJMRZ35.SGD","BK4578","BK4588","LU0208291251.USD","MEDX","BK4599","PBE","BK4007","LU1061106388.HKD","PJP","BK4534","BIB","BK4585","LU2089984988.USD","LU0868494617.USD","LU0289739699.SGD","LU0122379950.USD","LU2468319806.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2242652126.USD","BK1589","HK0000165453.HKD","AMGN","LU2468319806.SGD","BK1521","SG9999001440.SGD","LU1057294990.SGD","LU2089984988.USD","BK4566","LU0889565916.HKD","PJP","IBB","BBH","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1023059063.AUD","IBBQ","LU1061106388.HKD","IE00BZ08YR35.GBP","LU0058720904.USD","LU2242646821.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","IE00BZ08YS42.EUR","PBE","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","LU0109394709.USD","LU2112291526.USD","BK4139","TBXU","BK4588","IE0009355771.USD","BK4599","BIB","BK4533","BK1191","BK4581","LU1571399168.USD","BK4534","BK1515","LU0122379950.USD","01177","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","TRUH","MHIP","MEDI","VHT","NAMS","LU1571399168.USD","SGXZ99366536.SGD","FHLC","RXL","TBXU","OZEM","MEDX","ELIS","LU0823434583.USD","LU0097036916.USD","LLY","LU1267930730.SGD","ILDR","CANC","AMGN","PBE","BBH","IBBQ","WDNA","IXJ","JDOC","ELIL","BIB","SLN","THNR","PPH","LU2361044865.SGD","HRTS","CURE","FTXH","GDOC","LLYZ","LU2750360641.GBP","PJP","IBB","LU1691799644.USD","XLV","LU2089284900.SGD","LLYX","AGNG","IE00BJJMRY28.SGD","LLII","TMED","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104786890","title":"Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104786890","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104786890?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:22","pubTimestamp":1788765738,"startTime":"0","endTime":"0","summary":"Swiss pharma giant Novartis AG (NVS.US) has suffered another clinical trial setback, marking the second high-profile candidate to fail in late-stage studies within a single week. The latest casualty...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4599","LU0058720904.USD","BK4581","LU0211331839.USD","LU2089984988.USD","LU0320765992.SGD","TBXU","LU0109394709.USD","LU1023059063.AUD","IE0002141913.USD","IE00BJT1NW94.SGD","BIB","LU2468319806.SGD","BK4585","LU0070302665.USD","LU0320765489.SGD","MEDX","PPH","LU2112291526.USD","LU2242646821.SGD","BK4588","AMGN","LU1057294990.SGD","LU2242652126.USD","BK4007","BK4566","BK4139","LU1571399168.USD","BK4578","IBB","IE00BJJMRZ35.SGD","NVS","LU0868494617.USD","LU0889565916.HKD","IE0009355771.USD","SG9999001440.SGD","PJP","BBH","LU0208291251.USD","IE00B4R5TH58.HKD","BK4533","BK4534","LU1983299246.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","PBE","LU0122379950.USD","LU0289739699.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365115","title":"A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665365115?lang=en_us&edition=fundamental","pubTime":"2026-09-06 02:01","pubTimestamp":1788631260,"startTime":"0","endTime":"0","summary":"In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.Novartis saw U.S.-listed shares soar","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","TBXU","BK4504","LU0868494617.USD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0980610538.SGD","TFNS","LU2462157665.USD","LU2236285917.USD","LU0889565916.HKD","AMGN","PJP","BK4533","BK4599","LU2125154935.USD","SG9999001440.SGD","LU0320765489.SGD","LU2242652126.USD","BK4559","BK4566","IBB","LU0211331839.USD","BIB","LU0052756011.USD","LU1244550221.USD","BK4139","LU1162221912.USD","NVS","PBE","LU0314106906.USD","FTXO","LU1061106388.HKD","LU2360032135.SGD","IYF","LU1074936037.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4007","LU0128525689.USD","PPH","LU0106831901.USD","LU1983299246.USD","IE00BSNM7G36.USD","MEDX","BBH","LU2242646821.SGD","LU0130102774.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665682593","title":"Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2665682593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665682593?lang=en_us&edition=fundamental","pubTime":"2026-09-05 17:01","pubTimestamp":1788598891,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($ACRS) ), ( ($EYPT) ), ( ($VRTX) ), ( ($GTLB) ) and ( ($NB) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2417539215.USD","BBH","SG9999001176.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD","IBB","LU2456880835.USD","BK4607","IE0002270589.USD","LU1778281490.HKD","VRTX","BK4613","LU2468319806.SGD","LU1093756325.SGD","LU0417517546.SGD","LU1093756168.USD","SG9999013999.USD","GNMX","IE00B4R5TH58.HKD","LU1069344957.HKD","LU1674673428.USD","TBXU","BK4533","IE00BFTCPJ56.SGD","GTLB","PBE","LU1559883803.SGD","LU2236285917.USD","IBBQ","IE0002141913.USD","IE00B19Z9Z06.USD","LU1035775433.USD","IE00BJJMRZ35.SGD","EYPT","LU0079474960.USD","IDNA","IE0009355771.USD","IE00B2B36J28.USD","IE00B894F039.SGD","LU2462157665.USD","IE00B19Z9P08.USD","LU2362541513.USD","LU2089984988.USD","LU2324357040.USD","BIB","IE00B19Z3B42.SGD","LU0757428866.USD","VERX","LU0289739699.SGD","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665935260","title":"Royalty Pharma Announces Update on Novartis’ Phase 3 Topline Results for Pelacarsen","url":"https://stock-news.laohu8.com/highlight/detail?id=2665935260","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665935260?lang=en_us&edition=fundamental","pubTime":"2026-09-05 07:05","pubTimestamp":1788563100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUA8S5T7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RPRX","PBE","BK4007","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352983","title":"Royalty Pharma - Expects to Recoup Investment and Earn Modest Return Despite Pelacarsen Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352983?lang=en_us&edition=fundamental","pubTime":"2026-09-05 07:05","pubTimestamp":1788563100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nTUA8S5T7L:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBE","BK4007","IHE","RPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352504","title":"Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352504","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352504?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:53","pubTimestamp":1788562416,"startTime":"0","endTime":"0","summary":"Amgen EVP, CFO Thomas J.W. Dittrich files initial beneficial ownership statementAmgen EVP and CFO Thomas J.W. Dittrich reported 16,860 common shares in an initial SEC Form 3 filing.Disclaimer:This new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6SPhM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","PJP","LU0289739699.SGD","IBB","LU0058720904.USD","IE0002141913.USD","LU2112291526.USD","BK4599","LU2242646821.SGD","LU2242652126.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU0320765992.SGD","BK4566","LU1983299246.USD","BK4533","LU1023059063.AUD","LU1057294990.SGD","IBBQ","BIB","SG9999001440.SGD","AMGN","BK4534","IE0009355771.USD","TBXU","LU0109394709.USD","LU1571399168.USD","PBE","IE00BJT1NW94.SGD","LU2089984988.USD","BK4585","IE00BFTCPJ56.SGD","BK4581","BK4139","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0122379950.USD","BK4588","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665235617","title":"Amgen is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2665235617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665235617?lang=en_us&edition=fundamental","pubTime":"2026-09-05 02:47","pubTimestamp":1788547620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMGN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","LU2361044949.HKD","BK4559","LU0128525929.USD","PJP","BBH","BK4534","LU0868494617.USD","LU0787776722.HKD","FTXO","LU0154236417.USD","LU0708994859.HKD","BK4533","LU2361044865.SGD","IBB","PGF","LU1894683348.USD","LU0640476718.USD","LU0130517989.USD","TBXU","LU1074936037.SGD","IBBQ","LU0942090050.USD","LU0130102774.USD","LU1069347547.HKD","LU0971096721.USD","LU0162691827.USD","LU1814569148.SGD","BK4588","LU1035773651.USD","LU1571399168.USD","BK4582","LU0417517546.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0175139822.USD","BIB","IE00BJT1NW94.SGD","IE0009355771.USD","LU0889565916.HKD","TFNS","LU1061106388.HKD","AMGN","LU0310799852.SGD","LU0742534661.SGD","PBE","IYF","IE0002270589.USD","LU0106831901.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665935360","title":"This Biotech Wins a Big FDA Approval. Why Wall Street is Shrugging.","url":"https://stock-news.laohu8.com/highlight/detail?id=2665935360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665935360?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:13","pubTimestamp":1788538380,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals has won regulatory approval for a first-of-its kind drug targeting a rare brain disease, but Wall Street is shrugging off the news for a simple reason.Zilganersen, branded as Zan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE00B19Z9P08.USD","PBE","IONS","BK4588","BK4139","LU0889565916.HKD","BK4532","IE00B894F039.SGD","LABU","LU0109394709.USD","BMED","BK4585","LU0234570918.USD","IE00B19Z9Z06.USD","ARWR","BK4581","BIIB","XBI","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}